Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication availability). This article summarizes key recommendations from GINA 2021, and the evidence underpinning recent changes. GINA recommends that asthma in adults and adolescents should not be treated solely with short-acting β 2-agonist (SABA), because of the risks of SABA-only treatment and SABA overuse, and evidence for benefit of inhaled corticosteroids (ICS). Large trials show that as-needed combination ICS–formoterol reduces severe exacerbations by ⩾60% in mild asthma compared with SABA alone, with similar exacerbation, symptom, lung function, and inflammatory outcomes as daily ICS plus as-needed SABA. Key changes in GINA 2021 include division of the treatment figure for adults and adolescents into two tracks. Track 1 (preferred) has low-dose ICS–formoterol as the reliever at all steps: as needed only in Steps 1–2 (mild asthma), and with daily maintenance ICS–formoterol (maintenance-and-reliever therapy, “MART”) in Steps 3–5. Track 2 (alternative) has as-needed SABA across all steps, plus regular ICS (Step 2) or ICS–long-acting β 2-agonist (Steps 3–5). For adults with moderate-to-severe asthma, GINA makes additional recommendations in Step 5 for add-on long-acting muscarinic antagonists and azithromycin, with add-on biologic therapies for severe asthma. For children 6–11 years, new treatment options are added at Steps 3–4. Across all age groups and levels of severity, regular personalized assessment, treatment of modifiable risk factors, self-management education, skills training, appropriate medication adjustment, and review remain essential to optimize asthma outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926 · cited 2×
“uncontrolled despite optimized treatment with high-dose ICS–LABA or that requires such treatment to prevent it from becoming uncontrolled (12).”
Self-citationReddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L.-P., Boushey, H. A., Busse, W. W., Casale, T. B., Chanez, P., Enright, P. L., Gibson, P. G., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-060st · Cited by 1,918
Self-citationAllergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Brożek, J. L., Bousquet, J., Baena-Cagnani, C. E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schünemann, H. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.047 · Cited by 1,813
Low-Dose Inhaled Corticosteroids and the Prevention of Death from Asthma
Suissa, S., Ernst, P., Benayoun, S., Baltzan, M., & Cai, B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430504 · Cited by 1,100
Treatable traits: toward precision medicine of chronic airway diseases
Agusti, A., Bel, E., Thomas, M., Vogelmeier, C., Brusselle, G., Holgate, S., Humbert, M., Jones, P., Gibson, P. G., Vestbo, J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01359-2015 · Cited by 1,083
Self-citationJuniper, E. F., Svensson, K., Mörk, A.-C., & Ståhl, E. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2004.10.008 · Cited by 929
Waljee, A. K., Rogers, M. A. M., Lin, P., Singal, A. G., Stein, J. D., Marks, R. M., Ayanian, J. Z., & Nallamothu, B. K. (2017) · BMJ · doi:10.1136/bmj.j1415 · Cited by 830 · cited 2×
“38 (cid:4) Even occasional short courses of OCS (e.g., four to fi ve courses over 7 yr [i.e., less than one course per year]), are associated with signi fi cant short-term risks 39 and cumulative risks of long-term adverse effects such as osteoporosis and diabetes.”
The prevalence of severe refractory asthma
Hekking, P.-P. W., Wener, R. R., Amelink, M., Zwinderman, A. H., Bouvy, M. L., & Bel, E. H. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.042 · Cited by 813
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial
Pauwels, R. A., Pedersen, S., Busse, W. W., Tan, W. C., Chen, Y.-Z., Ohlsson, S. V., Ullman, A., Lamm, C. J., & O'Byrne, P. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12891-7 · Cited by 763
Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma
O’Byrne, P. M., FitzGerald, J. M., Bateman, E. D., Barnes, P. J., Zhong, N., Keen, C., Jorup, C., Lamarca, R., Ivanov, S., & Reddel, H. K. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715274 · Cited by 645
Self-citationManagement of severe asthma: a European Respiratory Society/American Thoracic Society guideline
Holguin, F., Cardet, J. C., Chung, K. F., Diver, S., Ferreira, D. S., Fitzpatrick, A., Gaga, M., Kellermeyer, L., Khurana, S., Knight, S., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00588-2019 · Cited by 629
Self-citationParsons, J. P., Hallstrand, T. S., Mastronarde, J. G., Kaminsky, D. A., Rundell, K. W., Hull, J. H., Storms, W. W., Weiler, J. M., Cheek, F. M., Wilson, K. C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201303-0437st · Cited by 603
The minimally important difference of the Asthma Control Test
Schatz, M., Kosinski, M., Yarlas, A. S., Hanlon, J., Watson, M. E., & Jhingran, P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.06.053 · Cited by 556
Risk factors for asthma: is prevention possible?
Beasley, R., Semprini, A., & Mitchell, E. A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00156-7 · Cited by 518
As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma
Bateman, E. D., Reddel, H. K., O’Byrne, P. M., Barnes, P. J., Zhong, N., Keen, C., Jorup, C., Lamarca, R., Siwek-Posluszna, A., & FitzGerald, J. M. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715275 · Cited by 516
Self-citationPrice, D. B., Trudo, F., Voorham, J., Xu, X., Kerkhof, M., Ling Zhi Jie, J., & Tran, T. N. (2018) · Journal of Asthma and Allergy · doi:10.2147/jaa.s176026 · Cited by 492
Severe Exacerbations and Decline in Lung Function in Asthma
O'Byrne, P. M., Pedersen, S., Lamm, C. J., Tan, W. C., & Busse, W. W. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1126oc · Cited by 474
Improving lung health in low-income and middle-income countries: from challenges to solutions
Meghji, J., Mortimer, K., Agusti, A., Allwood, B. W., Asher, I., Bateman, E. D., Bissell, K., Bolton, C. E., Bush, A., Celli, B., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00458-x · Cited by 470
Self-citationControlled Trial of Budesonide–Formoterol as Needed for Mild Asthma
Beasley, R., Holliday, M., Reddel, H. K., Braithwaite, I., Ebmeier, S., Hancox, R. J., Harrison, T., Houghton, C., Oldfield, K., Papi, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901963 · Cited by 466
Self-citationNwaru, B. I., Ekström, M., Hasvold, P., Wiklund, F., Telg, G., & Janson, C. (2020) · European Respiratory Journal · doi:10.1183/13993003.01872-2019 · Cited by 460
Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma
Aaron, S. D., Vandemheen, K. L., FitzGerald, J. M., Ainslie, M., Gupta, S., Lemière, C., Field, S. K., McIvor, R. A., Hernandez, P., Mayers, I., et al. (2017) · JAMA · doi:10.1001/jama.2016.19627 · Cited by 438
Self-citationWritten action plans for asthma: an evidence-based review of the key components
Gibson, P. G. (2004) · Thorax · doi:10.1136/thorax.2003.011858 · Cited by 432
Reddel, H. K., FitzGerald, J. M., Bateman, E. D., Bacharier, L. B., Becker, A., Brusselle, G., Buhl, R., Cruz, A. A., Fleming, L., Inoue, H., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01046-2019 · Cited by 390
Self-citationRescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild Asthma
Papi, A., Canonica, G. W., Maestrelli, P., Paggiaro, P., Olivieri, D., Pozzi, E., Crimi, N., Vignola, A. M., Morelli, P., Nicolini, G., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063861 · Cited by 365
Martinez, F. D., Chinchilli, V. M., Morgan, W. J., Boehmer, S. J., Lemanske, R. F., Mauger, D. T., Strunk, R. C., Szefler, S. J., Zeiger, R. S., Bacharier, L. B., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62145-9 · Cited by 341
Self-citationSobieraj, D. M., Weeda, E. R., Nguyen, E., Coleman, C. I., White, C. M., Lazarus, S. C., Blake, K. V., Lang, J. E., & Baker, W. L. (2018) · JAMA · doi:10.1001/jama.2018.2769 · Cited by 326
Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma
Suissa, S. (2002) · Thorax · doi:10.1136/thorax.57.10.880 · Cited by 322
Budesonide/Formoterol Maintenance Plus Reliever Therapy
Bisgaard, H., Le Roux, P., Bjåmer, D., Dymek, A., Vermeulen, J. H., & Hultquist, C. (2006) · Chest · doi:10.1378/chest.130.6.1733 · Cited by 315
Asthma and Adherence to Inhaled Corticosteroids: Current Status and Future Perspectives
Bårnes, C. B., & Ulrik, C. S. (2015) · Respiratory Care · doi:10.4187/respcare.03200 · Cited by 311
Preemptive Use of High-Dose Fluticasone for Virus-Induced Wheezing in Young Children
Ducharme, F. M., Lemire, C., Noya, F. J. D., Davis, G. M., Alos, N., Leblond, H., Savdie, C., Collet, J.-P., Khomenko, L., Rivard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808907 · Cited by 306
Systematic meta-review of supported self-management for asthma: a healthcare perspective
groups, F. T. P. A. R., Pinnock, H., Parke, H. L., Panagioti, M., Daines, L., Pearce, G., Epiphaniou, E., Bower, P., Sheikh, A., Griffiths, C. J., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0823-7 · Cited by 291
Self-citationOxygen therapy for acutely ill medical patients: a clinical practice guideline
Siemieniuk, R. A. C., Chu, D. K., Kim, L. H.-Y., Güell-Rous, M.-R., Alhazzani, W., Soccal, P. M., Karanicolas, P. J., Farhoumand, P. D., Siemieniuk, J. L. K., Satia, I., et al. (2018) · BMJ · doi:10.1136/bmj.k4169 · Cited by 281
Hardy, J., Baggott, C., Fingleton, J., Reddel, H. K., Hancox, R. J., Harwood, M., Corin, A., Sparks, J., Hall, D., Sabbagh, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31948-8 · Cited by 280
Self-citationLee, L. A., Bailes, Z., Barnes, N., Boulet, L.-P., Edwards, D., Fowler, A., Hanania, N. A., Kerstjens, H. A. M., Kerwin, E., Nathan, R., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30389-1 · Cited by 267
Self-citationDusser, D., Montani, D., Chanez, P., De Blic, J., Delacourt, C., Deschildre, A., Devillier, P., Didier, A., Leroyer, C., Marguet, C., et al. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01394.x · Cited by 247
Harrison, T., Oborne, J., Newton, S., & Tattersfield, A. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15384-6 · Cited by 229
Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?
Vogelmeier, C., D'Urzo, A., Pauwels†, R., Merino, J. M., Jaspal, M., Boutet, S., Naya, I., & Price, D. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00028305 · Cited by 221
Bousquet, J., Boulet, L.-P., Peters, M. J., Magnussen, H., Quiralte, J., Martinez-Aguilar, N. E., & Carlsheimer, Å. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.07.014 · Cited by 220
Self-citationVirchow, J. C., Kuna, P., Paggiaro, P., Papi, A., Singh, D., Corre, S., Zuccaro, F., Vele, A., Kots, M., Georges, G., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32215-9 · Cited by 215
Acute and chronic systemic corticosteroid–related complications in patients with severe asthma
Lefebvre, P., Duh, M. S., Lafeuille, M.-H., Gozalo, L., Desai, U., Robitaille, M.-N., Albers, F., Yancey, S., Ortega, H., Forshag, M., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.07.046 · Cited by 214
Patel, M., Pilcher, J., Pritchard, A., Perrin, K., Travers, J., Shaw, D., Holt, S., Harwood, M., Black, P., Weatherall, M., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70007-9 · Cited by 207
Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations
FitzGerald, J. M. (2004) · Thorax · doi:10.1136/thx.2003.014936 · Cited by 193 · cited 1×
“The timing of an increased ICS dose may be important: studies in adults in which the ICS dose was doubled 5–7 days after symptoms worsened found no reduction in severe exacerbations (76,77).”
Self-citationReddel, H. K., Busse, W. W., Pedersen, S., Tan, W. C., Chen, Y.-Z., Jorup, C., Lythgoe, D., & O'Byrne, P. M. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31399-x · Cited by 191
Self-citation“I have lost in every facet of my life”: the hidden burden of severe asthma
Foster, J. M., McDonald, V. M., Guo, M., & Reddel, H. K. (2017) · European Respiratory Journal · doi:10.1183/13993003.00765-2017 · Cited by 185
Self-citationShort-acting β-agonist use and its ability to predict future asthma-related outcomes
Stanford, R. H., Shah, M. B., D’Souza, A. O., Dhamane, A. D., & Schatz, M. (2012) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2012.08.014 · Cited by 182
Papi, A., Corradi, M., Pigeon-Francisco, C., Baronio, R., Siergiejko, Z., Petruzzelli, S., Fabbri, L. M., & Rabe, K. F. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70012-2 · Cited by 170
Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations
McKeever, T. M., Mortimer, K. J., Wilson, A., Walker, S. M., Brightling, C. E., Skeggs, A. L., Pavord, I. D., Price, D. B., Duley, L., Thomas, M. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714257 · Cited by 156
Self-citationSafety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma
Stempel, D. A., Szefler, S. J., Pedersen, S., Zeiger, R. S., Yeakey, A. M., Lee, L. A., Liu, A. H., Mitchell, H., Kral, K. M., Raphiou, I., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606356 · Cited by 148
Preventing Exacerbations in Preschoolers With Recurrent Wheeze: A Meta-analysis
Kaiser, S. V., Huynh, T., Bacharier, L. B., Rosenthal, J. L., Bakel, L. A., Parkin, P. C., & Cabana, M. D. (2016) · PEDIATRICS · doi:10.1542/peds.2015-4496 · Cited by 142
Self-citationPerrin, K., Wijesinghe, M., Healy, B., Wadsworth, K., Bowditch, R., Bibby, S., Baker, T. B., Weatherall, M., & Beasley, R. W. (2011) · Thorax · doi:10.1136/thx.2010.155259 · Cited by 129
A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care
Boulet, L., FitzGerald, J. M., Levy, M. L., Cruz, Á. A., Pedersen, S., Haahtela, T., & Bateman, E. (2012) · European Respiratory Journal · doi:10.1183/09031936.00184511 · Cited by 129
Self-citationPavord, I. D., Holliday, M., Reddel, H. K., Braithwaite, I. E., Ebmeier, S., Hancox, R. J., Harrison, T. W., Houghton, C., Oldfield, K., Papi, A. A., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30053-9 · Cited by 129
Self-citationGershon, A. S., Campitelli, M. A., Croxford, R., Stanbrook, M. B., To, T., Upshur, R., Stephenson, A. L., & Stukel, T. A. (2014) · JAMA · doi:10.1001/jama.2014.11432 · Cited by 121
Balanag, V. M., Yunus, F., Yang, P., & Jorup, C. (2005) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2005.04.009 · Cited by 112
Sobieraj, D. M., Baker, W. L., Nguyen, E., Weeda, E. R., Coleman, C. I., White, C. M., Lazarus, S. C., Blake, K., & Lang, J. E. (2018) · JAMA · doi:10.1001/jama.2018.2757 · Cited by 103
Lazarinis, N., Jørgensen, L., Ekström, T., Bjermer, L. H., Dahlén, B., Pullerits, T., Hedlin, G., Carlsen, K., & Larsson, K. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203557 · Cited by 97
Murphy, V. E., Bokern, M., McLaughlin, K., & Gibson, P. G. (2009) · Elsevier eBooks · doi:10.1007/978-1-59745-445-2_11 · Cited by 90
Sumino, K., Bacharier, L. B., Taylor, J., Chadwick-Mansker, K., Curtis, V. A., Nash, A., Jackson-Triggs, S., Moen, J., Schechtman, K. B., Garbutt, J. M., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.06.030 · Cited by 88
Self-citationReddel, H. K., Ampon, R. D., Sawyer, S. M., & Peters, M. J. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016688 · Cited by 87
Self-citationBarnes, P. J., Szefler, S. J., Reddel, H. K., & Chipps, B. E. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.06.040 · Cited by 83
Self-citationHiles, S. A., McDonald, V. M., Guilhermino, M. C., Brusselle, G., & Gibson, P. G. (2019) · European Respiratory Journal · doi:10.1183/13993003.01381-2019 · Cited by 83
Self-citationBateman, E. D., Harrison, T. W., Quirce, S., Reddel, H. K., Buhl, R., Humbert, M. J. C., Jenkins, C. R., Peterson, S., Östlund, O., O’Byrne, P. M., et al. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-38 · Cited by 81
Self-citationBudesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma
Jorup, C., Lythgoe, D., & Bisgaard, H. F. (2018) · European Respiratory Journal · doi:10.1183/13993003.01688-2017 · Cited by 81
O’Byrne, P. M., FitzGerald, J. M., Bateman, E. D., Barnes, P. J., Zheng, J., Gustafson, P., Lamarca, R., Puu, M., Keen, C., Alagappan, V., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30416-1 · Cited by 80
Self-citationBudesonide/formoterol maintenance and reliever therapy versus conventional best practice
Demoly, P. M., Louis, R. E., Søes‐Petersen, U., Naya, I. P., Carlsheimer, Å., Worth, H., Almeida, J., & Sears, M. R. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.07.018 · Cited by 56
Buhl, R., Kuna, P., Peters, M. J., Andersson, T. L., Naya, I. P., Peterson, S., & Rabe, K. F. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-59 · Cited by 53
Self-citationWilson, & Lipworth (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00058.x · Cited by 45
Asher, I., Bissell, K., Chiang, C., Sony, A. E., Ellwood, P. E., García‐Marcos, L., Marks, G. B., Mortimer, K. J., Pearce, N. E., & Strachan, D. P. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30513-7 · Cited by 45
Self-citationFollow-up after Acute Asthma Episodes: What Improves Future Outcomes?
Schatz, M. X., Rachelefsky, G. S., & Krishnan, J. A. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.p09st6 · Cited by 42
Self-citationSanyang, B., Jagne, E., Sefa, N., & Touray, S. (2020) · Journal of the Pan African Thoracic Society · doi:10.25259/jpats_19_2020 · Cited by 16
Cited by
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M. K., Martinez, F. J., Montes de Oca, M., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00239-2023 · Cited by 1,303
Self-citationGlobal Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M. K., Martinez, F. J., Montes de Oca, M., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202301-0106pp · Cited by 827
Self-citationMechanisms of airway epithelial injury and abnormal repair in asthma and COPD
Raby, K. L., Michaeloudes, C., Tonkin, J., Chung, K. F., & Bhavsar, P. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1201658 · Cited by 260
Lung imaging in COPD and asthma
Tanabe, N., Nakagawa, H., Sakao, S., Ohno, Y., Shimizu, K., Nakamura, H., Hanaoka, M., Nakano, Y., & Hirai, T. (2024) · Respiratory Investigation · doi:10.1016/j.resinv.2024.08.014 · Cited by 21
Prevalence and Clinical Outcomes of Eosinophilic COPD in a Saudi Population: A Retrospective Study
Alshehri, F., Alghamdi, M., Aloqabi, F. A., Ibrahim, A., Tayeb, N., Hassosah, M., Abu-Zaid, A., Fan, H., & Vali, Y. (2025) · Saudi Journal of Medicine & Medical Sciences · doi:10.4103/sjmms.sjmms_248_24 · Cited by 3
Metadata
- Authors
- Reddel, H. K., Bacharier, L. B., Bateman, E. D., Brightling, C. E., Brusselle, G. G., Buhl, R., Cruz, A. A., Duijts, L., Drazen, J. M., FitzGerald, J. M., Fleming, L. J., Inoue, H., Ko, F. W., Krishnan, J. A., Levy, M. L., Lin, J., Mortimer, K., Pitrez, P. M., Sheikh, A., Yorgancioglu, A. A., & Boulet, L.-P.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-01-01
- Volume
- 205
- Issue
- 1
- Pages
- 17-35
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3205425043
- Cited by
- 512
- References
- 72
- FWCI
- 40.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.